[1] 甄阳光,柏凡,张克英,等.我国主要饲料原料及产品中呕吐毒素污染分布规律研究[J].中国畜牧杂志,2009,45(8):21-24.
[2] TUTELYAN V A. Deoxynivalenol in cereals in Russia[J]. Toxicology Letters, 2004, 153(1):173-179.

[3] PESTKA J J. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance[J]. Archives of Toxicology, 2010, 84(9):663-679.

[4] PINTON A, FARAUT T, YERLE M, et al. Comparison of male and female meiotic segregation patterns in translocation heterozygotes: a case study in an animal model (
Sus scrofa domestica L.)[J]. Human Reproduction, 2005, 20(9):2476-2482.

[5] ERIKSEN G S, PETTERSSON H. Toxicological evaluation of trichothecenes in animal feed[J]. Animal Feed Science and Technology, 2004, 114(1/2/3/4):205-239.
[6] ACCENSI F, PINTON P, CALLU P, et al. Ingestion of low doses of deoxynivalenol does not affect hematological, biochemical, or immune responses of piglets[J]. Journal of Animal Science, 2006, 84(7):1935-1942.

[7] ISLAM Z, PESTKA J J. LPS priming potentiates and prolongs proinflammatory cytokine response to the trichothecene deoxynivalenol in the mouse[J]. Toxicology and Applied Pharmacology, 2006, 211(1):53-63.

[8] PESTKA J J, ZHOU H R, MOON Y, et al. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox[J]. Toxicology Letters, 2004, 153(1):61-73.

[9] PESTKA J.J. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions[J]. Toxicology Letters, 2003, 140/141:287-295.
[10] PESTKA J J, ZHOU H R. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion[J]. Food and Chemical Toxicology, 2000, 38(7):565-575.

[11] MOON Y, UZARSKI R, PESTKA J. Relationship of trichothecene structure to COX-2 induction in the macrophage: selective action of type B (8-keto) trichothecenes[J]. Journal of Toxicology and Environmental Health: Part A, 2003, 66(20):1967-1983.

[12] KOLF-CLAUW M, CASTELLOTE J, JOLY B, et al. Development of a pig jejunal explant culture for studying the gastrointestinal toxicity of the mycotoxin deoxynivalenol: histopathological analysis[J]. Toxicology in Vitro, 2009, 23(8):1580-1584.

[13] MARESCA M, MAHFOUD R, GARMY N, et al. The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells[J]. The Journal of Nutrition, 2002, 132(9):2723-2731.
[14] SERGENT T, PARYS M, GARSOU S, et al. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations[J]. Toxicology Letters, 2006, 164(2):167-176.

[15] PINTON P, NOUGAYRÈDE J P, DEL RIO J C, et al. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression[J]. Toxicology and Applied Pharmacology, 2009, 237(1):41-48.

[16] PINTON P, BRAICU C, NOUGAYREDE J P, et al. Deoxynivalenol impairs porcine intestinal barrier function and decreases the protein expression of claudin-4 through a mitogen-activated protein kinase-dependent mechanism[J]. The Journal of Nutrition, 2010, 140(11):1956-1962.

[17] ZHOU H R, ISLAM Z, PESTKA J J. Induction of competing apoptotic and survival signaling pathways in the macrophage by the ribotoxic trichothecene deoxynivalenol[J]. Toxicology Sciences, 2005, 87(1):113-122.

[18] PESTKA J J, UZARSKI R L, ISLAM Z. Induction of apoptosis and cytokine production in the Jurkat human T cells by deoxynivalenol: role of mitogen-activated protein kinases and comparison to other 8-ketotrichothecenes[J]. Toxicology, 2005, 206(2):207-219.

[19] UZARSKI R L, PESTKA J J. Comparative susceptibility of B cells with different lineages to cytotoxicity and apoptosis induction by translational inhibitors[J]. Journal of Toxicology and Environmental Health: Part A, 2003, 66(22):2105-2118.

[20] UZARSKI R L, ISLAM Z, PESTKA J J. Potentiation of trichothecene-induced leukocyte cytotoxicity and apoptosis by TNF-alpha and Fas activation[J]. Chemico-Biological Interactions, 2003, 146(2):105-119.

[21] SHI Y, PORTER K, PARAMESWARAN N, et al. Role of GRP78/BiP degradation and ER stress in deoxynivalenol-induced interleukin-6 upregulation in the macrophage[J]. Toxicology Sciences, 2009, 109(2):247-255.

[22] LE DREAN G, AUFFRET M, BATINA P, et al. Myelotoxicity of trichothecenes and apoptosis: an
in vitro study on human cord blood CD34+ hematopoietic progenitor[J]. Toxicology in Vitro, 2005, 19(8):1015-1024.

[23] YANG G H, JARVIS B B, CHUNG Y J, et al. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation[J]. Toxicology and Applied Pharmacology, 2000, 164(2):149-160.

[24] BENSASSI F, EI GOLLI-BENNOUR E, ABID-ESSEFI S, et al. Pathway of deoxynivalenol-induced apoptosis in human colon carcinoma cells[J]. Toxicology, 2009, 264(1/2):104-109.
[25] 丁举静,何成华,刘俐君,等.脱氧雪腐镰刀菌烯醇对BHK-21细胞的线粒体膜电位及Bax和Bcl-2蛋白表达的影响[J].南京农业大学学报,2011,34(2):101-106.
[26] WANG T, LIU C Z, YU J C, et al. Acupuncture protected cerebral multi-infarction rats from memory impairment by regulating the expression of apoptosis related genes Bcl-2 and Bax in hippocampus[J]. Physiology & Behavior, 2009, 96(1):155-161.

[27] CALVERT T W, AIDOO K E, CANDLISH A G, et al. Comparison of
in vitro cytotoxicity of
Fusarium mycotoxins, deoxynivalenol, T-2 toxin and zearalenone on selected human epithelial cell lines[J]. Mycopathologia, 2005, 159(3):413-419.

[28] MOON Y, PESTKA J J. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases[J]. Toxicology Sciences, 2002, 69(2):373-382.

[29] MOON Y, PESTKA J J. Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin (deoxynivalenol)
in vitro and
in vivo[J]. Toxicology and Applied Pharmacology, 2003, 187(2):80-88.

[30] CHUNG Y J, ZHOU H R, PESTKA J J. Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin)[J]. Toxicology and Applied Pharmacology, 2003, 193(2):188-201.

[31] WONG S S, ZHOU H R, PESTKA J J. Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappaB, and NF-IL6 in raw 264.7 macrophage cells[J]. Journal of Toxicology and Environmental Health: Part A, 2002, 65(16):1161-1180.

[32] TSUKADA J, YOSHIDA Y, KOMINATO Y, et al. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation[J]. Cytokine, 2011, 54(1):6-19.

[33] ZHOU H R, LAU A S, PESTKA J J. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response[J]. Toxicology Sciences, 2003, 74(2):335-344.

[34] LI M, PESTKA J J. Comparative induction of 28S ribosomal RNA cleavage by ricin and the trichothecenes deoxynivalenol and T-2 toxin in the macrophage[J]. Toxicology Sciences, 2008, 105(1):67-78.

[35] DIXON D A, KAPLAN C D, MCLNTYRE T M, et al. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region[J]. The Journal of Biological Chemistry, 2000, 275(16):11750-11757.

[36] ZHOU H R, ISLAM Z, PESTKA J J. Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin[J]. Toxicology Sciences, 2003, 72(1):130-142.

[37] BULLERMAN L B, BIANCHINI A. Stability of mycotoxins during food processing[J]. International Journal of Food Microbiology, 2007, 119(1/2):140-146.
[38] BRETZ M, BEYER M, CRAMER B, et al. Thermal degradation of the
Fusarium mycotoxin deoxynivalenol[J]. Journal of Agricultural and Food Chemistry, 2006, 54(17):6445-6451.

[39] MURATA H, MITSUMATSU M, SHIMATSU N. Reduction of feed-contaminating mycotoxins by ultraviolet irradiation: an
in vitro study[J]. Food Additives & Contaminants: Part A, 2008, 25(9):1107-1110.

[40] PARK B J, TAKATORI K, SUGITA-KONISHI Y, et al. Degradation of mycotoxins using microwave-induced argon plasma at atmospheric pressure[J]. Surface and Coatings Technology, 2007, 201(9/10/11):5733-5737.
[41] YOUNG J C, BLACKWELL B A, APSIMON J W. Alkaline-degradation of the mycotoxin 4-deoxynivalenol[J]. Tetrahedron Letters, 1986, 27(9):1019-1022.